The FDA approves Hologic's (HOLX) Cervista HTA system for use with the company's previously...


The FDA approves Hologic's (HOLX) Cervista HTA system for use with the company's previously approved Cervista human papillomavirus HR test. The technology is used to detect 14 high risk types of HPV that are associated with cervical cancer and precancerous lesions. Shares +1.2% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs